SenesTech, Inc. (SNES)
After hours:
| Previous close | 0.8613 |
| Open | 0.8800 |
| Bid | 0.6020 x 200 |
| Ask | 1.1100 x 200 |
| Day's range | 0.8403 - 0.8800 |
| 52-week range | 0.5200 - 19.2000 |
| Volume | |
| Avg. volume | 176,893 |
| Market cap | 4.436M |
| Beta (5Y monthly) | 0.77 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
SenesTech to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
SenesTech, Inc. (NASDAQ: SNES) will report financial results for its first quarter 2024, ended March 31, 2024, after the market close on Thursday, May 9, 2024. The Company has scheduled a conference call that same day, Thursday, May 9, 2024, at 5:00 pm ET, to review the results.
- PR Newswire
SenesTech Launches Evolve™ Mouse
SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces that the Company has launched Evolve™ Mouse, utilizing a breakthrough fertility control solution, for the control of mouse infestations. Evolve Mouse is designated as a 'minimum risk' product by the U.S. Environmental Protection Agency, posing little to no risk to human health and the environment. The Company will be accepting orders as of Monday, May 6
- PR Newswire
SenesTech to Present at the Emerging Growth Conference on April 3, 2024
SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced that its Chief Executive Officer, Joel Fruendt, will be participating in the Emerging Growth Conference.
